Radionuclide tracers in the evaluation of resting myocardial ischaemia and viability

European Journal of Nuclear Medicine

Volumn 24, Issue 9, 1997, Pages 1183-1193

  Opie, L H ^a,b   Hesse, B ^c  

^a UNIVERSITY OF CAPE TOWN   (South Africa)

^b UNIVERSITY OF CAPE TOWN   (South Africa)

^c Mental Health Services CPH   (Denmark)

Author keywords

Deoxyglucose; Hibernation; Myocardial ischaemia; Nitroimidazole

Indexed keywords

CARBON 11; FLUORODEOXYGLUCOSE F 18; METHOXY ISOBUTYL ISONITRILE TECHNETIUM TC 99M; NITROIMIDAZOLE DERIVATIVE; TETROFOSMIN TC 99M; THALLIUM 201;

GLUCOSE TRANSPORT; HEART MUSCLE ISCHEMIA; HEART SCINTISCANNING; HUMAN; POSITRON EMISSION TOMOGRAPHY; REVIEW; SCINTILLATION CAMERA;

EID: 0030865764     PISSN: 03406997     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF01254255     Document Type: Review

References (60)

1. Hearse DJ. Myocardial ischaemia: can we agree on a definition for the 21st century? Cardiovasc Res 1994; 28: 1737-1744.
2. Iskandrian AS, Heo J, Schelbert HR. Myocardial viability: methods of assessment and clinical relevance. Am Heart J 1996; 132: 1226-1235.
3. Depré C, Vanoverschelde J-L, Gerber B, et al. Correlation of functional recovery with myocardial blood flow, glucose uptake, and morphologic features in patients with chronic left ventricular ischaemic dysfunction undergoing coronary artery bypass grafting. J Thorac Cardiovasc Surg 1997; 113: 371-378.
4. Tillisch J, Brunken R, Marshall R, et al. Reversibility of cardiac wall-motion abnormalities predicted by positron emission tomography. N Engl J Med 1986; 314: 884-888.
5. Tamaki N, Yonekura Y, Yamashita K, et al. Positron emission tomography using fluorine-18 deoxyglucose in evaluation of coronary artery bypass grafting. Am J Cardiol 1989; 64: 860-865.
6. Tamaki N, Ohtani H, Yamashita K, et al. Metabolic activity in the areas of new fill-in after thallium-201 reinjection: comparison with positron emission tomography using fluorine-18-deoxyglucose. J Nucl Med 1991; 32: 673-678.
7. Saha GB, MacIntyre WJ, Brunken RC, et al. Present assessment of myocardial viability by nuclear imaging. Semin Nucl Med 1996; 26: 315-335.
8. 87Rb NMR spectroscopic study. Magn Reson Med 1995; 34: 673-685.
9. Bonow RO, Dilsizian V, Cuocolo A, Bacharach SL. Identification of viable myocardium in patients with chronic coronary artery disease and left ventricular dysfunction. Circulation 1991; 83: 26-37.
10. Beanlands RS, Dawood F, Wen W-H, et al. Are the kinetics of technetium-99m methoxyisobutyl isonitrile affected by cell metabolism and viability? Circulation 1990; 82: 1802-1814.
11. Miller DD. The growing flood of technetium-99m myocardial perfusion agents. Circulation 1995; 91: 555-558.
12. Strauss HW, Nunn A, Linder K. Nitroimidazoles for imaging hypoxic myocardium. J Nucl Cardiol 1995; 2: 437-445.
13. Gropler RJ, Geltman EM, Sampathkumaran K, et al. Comparison of carbon-11-acetate with fluorine-18-fluorodeoxyglucose for delineating viable myocardium by positron emission tomography. J Am Coll Cardiol 1993; 22: 1587-1597.
14. Tamaki N, Tadamura E, Kudoh T, et al. Prognostic value of iodine-123 labelled BMIPP fatty acid analogue imaging in patients with myocardial infarction. Eur J Nucl Med 1996; 23: 272-279.
15. Knapp FF. Myocardial metabolism of radioiodinated BMIPP. J Nucl Med 1995; 36: 1051-1054.
16. Miller DD, Gill JB, Livini E, et al. Fatty acid analogue accumulation: a marker of myocyte viability in ischaemic-reperfused myocardium. Circ Res 1988; 63: 681-692.
17. 1H NMR spectroscopic imaging of myocardial triglycerides in excised dog hearts subjected to 24 hours of coronary occlusion. Circulation 1996; 93: 1464-1470.
18. Rahimtoola SH. The hibernating myocardium. Am Heart J 1989; 117: 211-221.
19. 99mTc-sestamibi in cultured chick ventricular myocytes during ATP depletion. Circulation 1992; 85: 1531-1541.
20. Schelbert HR. Different roads to the assessment of myocardial viability. Lessons from PET for SPECT. Circulation 1995; 91: 1894-1895.
21. Bax JJ, Cornel JH, Visser FC, et al. Prediction of recovery of myocardial dysfunction after revascularization. Comparison of fluorine-18 fluorodeoxyglucose/thallium-201 SPECT, thallium-201 stress-reinjection SPECT and dobutamine echocardiography. J Am Coll Cardiol 1996; 28: 558-564.
22. Delbeke D, Videlefsky S, Patton JA, Campbell MG, Martin WH. Rest myocardial perfusion/metabolism imaging using simultaneous dual-isotope acquisition SPECT with technetium-99m-MIBI/fluorine-18-FDG. J Nucl Med 1995; 36: 2110-2119.
23. 3. Circulation 1983; 68 Suppl III: 111-387.
24. Shivalkar B, Maes A, Borgers M, et al. Only hibernating myocardium invariably shows early recovery after coronary revascularization. Circulation 1996; 94: 308-315.
25. Bonow RO. Identification of viable myocardium. Circulation 1996; 94: 2674-2680.
26. King LM, Boucher F, Opie LH. Coronary flow and glucose delivery as determinants of contracture in the ischaemic myocardium. J Mol Cell Cardiol 1995; 27: 701-720.
27. King LM, Boucher FR, Opie LH. Glucose uptake in the myocardium with changes in coronary flow and glucose concentration - theoretical basis of positron emission tomography 'mismatch' concept. Eur Heart J 1996; 17: 16.
28. Stanley WC, Hall JL, Stone CK, Hacker TA. Acute myocardial ischaemia causes a transmural gradient in glucose extraction but not glucose uptake. Am J Physiol 1992; 262: H91-H96.
29. Caldwell JH, Revenaugh JR, Martin GV, et al. Comparison of fluorine-18-fluorodeoxyglucose and tritiated fluoromisonidazole uptake during low-flow ischaemia. J Nucl Med 1995; 36: 1633-1638.
30. Gerber BL, Vanoverschelde J-L, Bol A, et al. Myocardial blood flow, glucose uptake, and recruitment of inotropic reserve in chronic left ventricular ischaemic dysfunction. Implications for the pathophysiology of chronical myocardial hibernation. Circulation 1996; 94: 651-659.
31. Di Carli MF, Asgarzadie F, Schelbert HR, et al. Quantitative relation between myocardial viability and improvement in heart failure symptoms after revascularization in patients with ischaemic cardiomyopathy. Circulation 1995; 92: 3436-3444.
32. 18F]2-deoxy-2-fluoro-D-glucose for assessing myocardial glucose uptake. Circulation 1995; 91: 2435-2444.
33. Bøtker HE, Guthrie P, Nielsen TT, el al. Determination of individual lumped constants with (18-F) fluorodeoxyglucose. Circulation 1996; 94 Suppl I: 1-542.
34. Opie LH. Metabolism of the heart in health and disease. Part 1. Am Heart J 1968; 76: 685-698.
35. Camici P, Ferrannini E, Opie LH. Myocardial metabolism in ischaemic heart disease: basic principles and application to imaging by positron emission tomography. Prog Cardiovasc Dis 1989; 32: 217-238.
36. Marinho NVS, Keogh BE, Costa DC, et al. Pathophysiology of chronic left ventricular dysfunction. New insights from the measurement of absolute myocardial blood flow and glucose utilization. Circulation 1996; 93: 737-744.
37. Maki M, Luotalahti M, Nuutilia P, et al. Glucose uptake in the chronically dysfunctional but viable myocardium. Circulation 1996; 93: 1658-1666.
38. Knuuti MJ, Maki M, Yki-Jarvinen H, et al. The effect of insulin and FFA on myocardial glucose uptake. J Mol Cell Cardiol 1995; 27: 1359-1367.
39. Vanoverschelde J-LJ, Wijns W, Depré C, et al. Mechanisms of chronic regional postischaemic dysfunction in humans. New insights from the study of noninfarcted collateral-dependent myocardium. Circulation 1993; 87: 1513-1523.
40. vom Dahl J, Herman WH, Hicks RJ, et al. Myocardial glucose uptake in patients with insulin-dependent diabetes mellitus assessed quantitatively by dynamic positron emmison tomography. Circulation 1993; 88: 395-404.
41. Randle PJ, Garland PB, Hales CN, Newsholme EA. The glucose-fatty acid cycle. Its role in insulin sensitivity and the metabolic disturbances of diabetes mellitus. Lancet 1963; 785-789.
42. Owen P, Dennis S, Opie LH. Glucose flux rate regulates onset of ischaemic contracture in globally underperfused rat hearts. Circ Res 1990; 66: 344-354.
43. Knuuti PN, Knuuti MJ, Raitakari M, et al. Effect of antilipolysis on heart and skeletal muscle glucose uptake in overnight fasted humans. Am J Physiol 1994; 267: E941-E946.
44. 99mTc-HL91. Effects of low flow and hypoxia on a new ischaemia-avid myocardial imaging agent. Circulation 1997; 95: 1892-1899.
45. Kalff V, Schwaiger M, Nguyen N, et al. The relationship between myocardial blood flow and glucose upatake in ischaemic canine myocardium determined with fluorine-18-deoxyglucose. J Nucl Med 1992; 33: 1346-1353.
46. Prellwitz JA, Vasta MC, Sunderland JJ, et al. Investigation of factors influencing FDG myocardial image quality. J Nucl Med 1991; 32: 1039.
47. Diamond GA, Forrester FS, deLuz PL, et al. Post-extrasystolic potentiation of ischaemic myocardium by atrial stimulation. Am Heart J 1978; 95: 204-209.
48. Rahimtoola SH. A perspective on three large multicentre randomized clinical trials of coronary bypass surgery for chronic stable angina. Circulation 1985; 72 Suppl V: 123-135.
49. Rahimtoola SH. Hibernating myocardium has reduced blood flow at rest that increases with low-dose dobutamine. Circulation 1996; 94: 3055-3061.
50. Arai AE, Grauer SE, Anselone CG, et al. Metabolic adaptation to a gradual reduction in myocardial blood flow. Circulation 1995; 92: 244-252.
51. 18-F-2-Deoxyglucose deposition and regional flow in pigs with chronically dysfunctional myocardium. Evidence for transmural variations in chronic hibernating myocardium. Circulation 1997; 95: 1900-1909.
52. Vanoverschelde J-L, Wijns M, Borgers M, et al. Chronic myocardial hibernation in humans. From bedside to bench. Circulation 1997; 95: 1961-1971.
53. 15O] water techniques. Circulation 1996; 93: 2000-2006.
54. Beanlands RS, Scheffel A, Nahmias C, et al. Can nitrogen-13 ammonia kinetic modelling define myocardial viability independent of fluorine-18 fluorodeoxyglucose? J Am Coll Cardiol 1997;29:537-543.
55. Opie LH. Reperfusion injury and its pharmacologic modification. Circulation 1989; 80: 1049-1062.
56. Hearse DJ. Stunning: a radical review. Cardiovasc Drugs Ther 1991; 5: 853-876.
57. Shen YT, Vatner SF. Mechanism of impaired myocardial function during progressive coronary stenosis in conscious pigs. Hibernation versus stunning. Circ Res 1995; 76: 479-488.
58. Park SW, Tang XL, Qiu Y, et al. Nisoldipine attenuates myocardial stunning induced by multiple coronary occlusions in conscious pigs and this effect is independent of changes in hemodynamics or coronary blood flow. J Mol Cell Cardiol 1996; 28: 655-666.
59. Schöder H, Knight RJ, Kofoed KF, et al. Effects of dichloracetate (DCA) on glucose metabolism in postischaemic myocardium in vivo. Eur J Nucl Med 1996; 23: 1046.
60. Di Carli M, Choi Y, Schelbert HR, et al. Clinical significance of reduced glucose uptake in myocardial regions with preserved blood flow in patients with coronary artery disease [Abstract]. J Am Coll Cardiol 1996; 27 Suppl: 163A.